Serum and Urine Tissue Kallikrein Concentrations in Male-to-Female Transsexuals Treated with Antiandrogens and Estrogens | Zendy

Margrita H Slagter | Zendy; Louis Gooren | Zendy; Willem de Ronde | Zendy; Antoninus Soosaipillai | Zendy; Andreas Scorilas | Zendy; Erik J. Giltay | Zendy; Miltiadis Paliouras | Zendy; Eleftherios P. Diamandis | Zendy

Open Access

Serum and Urine Tissue Kallikrein Concentrations in Male-to-Female Transsexuals Treated with Antiandrogens and Estrogens

Author(s) -

Margrita H Slagter,

Louis Gooren,

Willem de Ronde,

Antoninus Soosaipillai,

Andreas Scorilas,

Erik J. Giltay,

Miltiadis Paliouras,

Eleftherios P. Diamandis

Publication year - 2006

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2006.068932

Subject(s) - kallikrein , endocrinology , medicine , estrogen , antiandrogen , urine , cyproterone acetate , ethinylestradiol , androgen , hormone , biology , population , biochemistry , environmental health , research methodology , enzyme

The expression of human tissue kallikrein genes is regulated by steroid hormones, but most studies have been conducted with cancer cell lines. Our purpose was to examine serum and urinary tissue kallikrein concentration changes in male-to-female transsexuals before and after treatment with antiandrogens and estrogens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research